OncoPanels with DNBSEQ

On Demand

1hr 59mins

Share webinar

1hr 59mins

Comprehensive genomic profiling is essential for precision oncology. The speakers evaluated cancer gene panels on MGI's G400 and G99 DNBSEQ systems. Agilent's assay offers tumor profiling on G400; GenePLUS has a 1021-gene panel; NGeneBio targets 18-343 genes for various cancers. These systems achieve >90% Q30, >50X coverage, detecting variants down to 1% allele frequency. MGI's systems offer speed, scalability, and cost-effectiveness, supporting both large and targeted panels for cancer research and diagnostics, advancing genomic medicine.

William TAN, PhD BCMAS

Dr. William Tan Associate Director @MiRXES

Dr. Michael Ruvolo  Director, R&D  @Agilent Technologies

Dr. Michael Ruvolo Director, R&D @Agilent Technologies

Xiaorui (Harry) Han

Dr. Xiaorui Han Overseas Product Manager @Geneplus

Dr. Felicity Hall Senior Global Product Manager @Agilent Technologies

Dr. Felicity Hall Senior Global Product Manager @Agilent Technologies

Dr. Kathy K.S. Lee Team leader @NGeneBio

Dr. Kathy K.S. Lee Team leader @NGeneBio

pagination here
pagination here
Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.